MREO Mereo BioPharma Group plc
Healthcare$0.28+2.28%ClosedMarket Cap: $44.4M
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$0.83
Target (Median)
$1.00
Target Range
$0.50 - $1.00
Upside from current price: 199.4%
Rating Distribution
1 Strong Buy4 Buy3 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-12 | BTIG | maintain | Buy | Buy |
| 2026-03-23 | JP Morgan | downgrade | Neutral | Overweight |
| 2026-01-16 | BTIG | maintain | Buy | Buy |
| 2026-01-13 | Needham | maintain | Buy | Buy |
| 2025-12-30 | Jefferies | downgrade | Hold | Buy |
| 2025-12-29 | LifeSci Capital | downgrade | Market Perform | Outperform |
| 2025-08-25 | JP Morgan | maintain | Overweight | Overweight |
| 2025-07-10 | Needham | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-0.01 | $27.1M | 4 |
| Sun Dec 31 | $0.12 | $48.2M | 2 |
| Mon Dec 31 | $-0.06 | $28.8M | 1 |
| Tue Dec 31 | $0.01 | $104.3M | 1 |